A fully integrated global biosimilars company, all in on biosimilars.
A long-standing presence in the biosimilars industry
Biocon Biologics has emerged as a leading biosimilars player in Europe and worldwide, providing innovative and more affordable ways to treat diabetes, cancer, and autoimmune diseases. As a result of its successful global partnership with Viatris, Biocon Biologics has broadened its biosimilars capability from lab to market, commercializing the products it has been manufacturing for years.